 Combination therapy recombinant human interferon alpha A/D viral myocarditis mice starting infection effects recombinant human interferon alpha A/D rIFN A/D combination drugs murine acute myocarditis due virus Mice KE U/g rIFN alpha A/D hr viral inoculation days survival rate mice combination therapy untreated mice day viral titer heart heart weight/body ratio scores myocardial inflammation necrosis hand therapy alpha A/D survival rate extent myocardial damage natural killer cell activity combination therapy mice day infection comparison untreated mice cytotoxicity peritoneal macrophages combination therapy alpha A/D effective therapy alpha A/D acute viral myocarditis treatment infection stimulation host immunologic response important combination therapy